Company news
Biostax Corp. (OTC:BTAX) news
Biostax Corp. news releases on 6ix. Latest, Jan 26, 2015: ClearTrust, LLC is Immune Therapeutics' New Transfer Agent and Support Provider
Press releases — page 2
ClearTrust, LLC is Immune Therapeutics' New Transfer Agent and Support Provider
January 26, 2015
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
January 23, 2015
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
January 21, 2015
Immune Therapeutics Inc. Announces Appointment of New President and Chief Operating Officer
January 14, 2015
The Jack Brewer Foundation and Immune Therapeutics Inc. Announce Medical Equipment Donation Program for the Prevention of Cervical Cancer in Africa to be Unveiled Today at the United Nations
January 8, 2015
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress
January 5, 2015
TNI BioTech, Inc. through its wholly owned subsidiary TNI BioTech International Ltd., provides progress report on bridging trial for HIV/AIDS in Nigeria
December 4, 2014
TNI BioTech, Inc. Provides Extension of Delivery of Shares to the Transfer Agent
December 1, 2014
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS
October 30, 2014
TNIB announced a spin-off of restricted shares of Cytocom, Inc with a record date of 9/30/2014. TNIB will not be quoted ex-dividend
September 30, 2014
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend
September 29, 2014
TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible
September 23, 2014
TNI BioTech Announces Results of Annual Shareholders Meeting
September 9, 2014
TNI BioTech Inc. Announces First Shipment of Lodonal® to The Republic of Panama and The Republic of Malawi
August 27, 2014
TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014
August 18, 2014
TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014
August 14, 2014
TNI BioTech and Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement
August 13, 2014
TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card
July 28, 2014
TNI BioTech, Inc. Establishes New Record Date for Spin-Off Stock Dividend of Cytocom, Inc. Shares
July 14, 2014
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa - CORRECTION
June 25, 2014
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa
June 25, 2014
TNI BioTech, Inc. Cancels Proposed Reverse Split of its Common Stock
June 24, 2014
TNI BioTech, Inc. Files Schedule 14A and Announces Annual Meeting
June 18, 2014
TNI BioTech, Inc. Obtains Drug Approval For Sale of Low Dose Naltrexone (LDN) From Government of Malawi
May 6, 2014
TNI BioTech, Inc. Announces Proposed Spin-Off of Cytocom, Inc.
May 1, 2014
TNI BioTech, Inc. Announces Further Agreement on Methionine-Enkephalin with Hubei Qianjiang Pharmaceutical Co., Ltd.
March 26, 2014
TNI BioTech, Inc. Granted Additional Patent for Methods for Inducing Sustained Immune Response of T-Cells
March 12, 2014
The Brewer Group Announces Strategic Partnership with TNI BioTech, Inc.
March 7, 2014
TNI BioTech, Inc. Forms New Subsidiary, Cytocom Inc., to develop LDN and MENK
March 6, 2014
TNI BIOTECH Announces SEC Clearance Of Form 10 Registration Statement And Clears Way To Upgrade To A Higher Exchange
February 11, 2014
TNI BioTech, Inc. Subsidiary Granted Certificate of Free Sale by Nicaraguan Minister of Health for Low Dose Naltrexone
December 3, 2013
Micro-Cap Review Magazine Fall/Winter 2013 Issue Now Available on StockNewsNow.com and MicroCapReview.com
October 15, 2013
TNI BioTech, Inc. Announces Distribution Agreement Between AHAR Pharma for Lodonal(TM) and TNI BioTech International, LTD for Nigerian Market
October 2, 2013
TNI BioTech, Inc. Announces Mandatory Exchange of Common Stock Certificates CUSIP Number 872608104 for New Stock Certificates with Active CUSIP 872608203
June 7, 2013
TNI BioTech, Inc. Announces Death of Senior Vice President and Chief Medical Officer, Dr. Ronald Herberman
June 3, 2013
TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
May 20, 2013
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events
May 16, 2013
TNI BioTech, Inc. Receives Confirmation of Transfer of IND application and Orphan Drug Designation
May 5, 2013
TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
April 30, 2013
TNI BioTech Names Terry Lierman of Summit Global Ventures as a Strategic Advisor
April 25, 2013
TNI BioTech Files Form 10 with SEC
April 22, 2013
TNI BioTech, Inc. Completes Financial Audit
April 8, 2013
Equatorial Guinea's [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
April 8, 2013
TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
February 1, 2013
TNI BioTech, Inc. Announces Appointment of New CFO
January 22, 2013
TNI BioTech, Inc. Acquires the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists for the Treatment of Inflammatory and Ulcerative Diseases of the Bowel
January 8, 2013
Dr. Henry “Skip” Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
October 10, 2012
The Government of Malawi & TNI Biotech sign agreement to open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
September 25, 2012
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
September 12, 2012
TNI BioTech, Inc. Acquires Exclusive License to the Portfolio of Patents of Dr. Bernard Bihari
August 27, 2012